BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7884589)

  • 21. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
    J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.
    Eneström S; Vavruch L; Frånlund B; Nordenskjöld B
    Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ; DeRose PB; Cohen C
    Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
    Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded material.
    Rautiainen E; Haapasalo H; Sallinen P; Rantala I; Helen P; Helin H
    Histopathology; 1998 Jan; 32(1):43-50. PubMed ID: 9522215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
    Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
    Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.